Anzeige
Meldung des Tages: Gold-Rally ohne Ende? Diese 1-Mio.-Unzen-Story in Westafrika könnte der nächste Hebel auf den Boom sein

Quest Diagnostics Aktie News

Aktie
WKN:  904533 ISIN:  US74834L1008 US-Symbol:  DGX Land:  USA
188,95 $
+0,00 $
0,00%
161,24 € 01:00:00 Uhr
Depot/Watchlist
Marktkapitalisierung *
16,68 Mrd. €
Streubesitz
0,32%
KGV
19,57
Dividende
0,80 $
Dividendenrendite
0,42%
neu: Nachhaltigkeits-Score
35 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,32: MJ1B7E
Werbung

Quest Diagnostics News

15.08.25 - PR Newswire
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference PR Newswire
13.08.25 - PR Newswire
Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics Declares Quarterly Cash Dividend PR Newswire
07.08.25 - PR Newswire
Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types
Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-​surgical Treatment for Two Cancer Types PR Newswire
05.08.25 - PR Newswire
Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care
Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care PR Newswire
29.07.25 - PR Newswire
Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing
Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing PR Newswire
22.07.25 - PR Newswire
Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 PR Newswire
15.07.25 - PR Newswire
Quest Diagnostics Introduces Testing for Oropouche Virus
Quest Diagnostics Introduces Testing for Oropouche Virus PR Newswire
09.07.25 - PR Newswire
Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease
Quest Diagnostics to Offer FDA-​Cleared Fujirebio Blood Test for Alzheimer's Disease PR Newswire
25.06.25 - PR Newswire
Quest Diagnostics Releases 2024 Corporate Responsibility Report
Quest Diagnostics Releases 2024 Corporate Responsibility Report PR Newswire
23.06.25 - PR Newswire
Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025
Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025 PR Newswire
10.06.25 - PR Newswire
Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
Quest Diagnostics to Develop Multi-​cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology PR Newswire
20.05.25 - PR Newswire
More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals
More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals PR Newswire
16.05.25 - PR Newswire
Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference
Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference PR Newswire
14.05.25 - PR Newswire
Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics Declares Quarterly Cash Dividend PR Newswire
13.05.25 - PR Newswire
Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds
Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds PR Newswire
22.04.25 - PR Newswire
Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025
Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 PR Newswire
09.04.25 - PR Newswire
Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease
Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease PR Newswire
02.04.25 - PR Newswire
Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening
Quest Diagnostics Introduces HPV Specimen Self-​Collection for Cervical Cancer Screening PR Newswire
01.04.25 - PR Newswire
Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025
Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025 PR Newswire
19.03.25 - PR Newswire
Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day
Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day PR Newswire

Newssuche

Videos

newspaper
20.01.26 +2,43%
Technical Trading: Gold Zukauf
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »